USP Water Testing for Pharmaceutical Manufacturers

USP Water Testing: What Pharmaceutical Manufacturers Need to Know

Water is one of the most widely used materials in pharmaceutical manufacturing. It may be used as a product ingredient, processing aid, cleaning agent, final rinse, laboratory reagent or utility supporting critical operations. Because water can carry chemical impurities, microorganisms and bacterial endotoxins, its quality must be appropriate for its intended use—and consistently maintained throughout the system.

USP water testing is therefore more than collecting a sample and comparing a result with a specification. An effective program connects the water type, system design, sampling location, test method, operating conditions and historical trends to demonstrate that the system remains in control.

Start With the Water’s Intended Use

The first step is determining the quality of water required for the application. Two commonly used bulk pharmaceutical waters are:

• Purified Water, USP: Commonly used in nonparenteral manufacturing, equipment cleaning, laboratory applications and other processes where the applicable formulation or procedure requires Purified Water.
• Water for Injection, USP: Used where greater control of microbial contamination and bacterial endotoxins is required, including many parenteral manufacturing applications.

The correct water type should be based on the product, manufacturing stage, route of administration, applicable monograph and process risk. A facility may also establish requirements that are more stringent than the compendial criteria when necessary to protect its products and processes.

The FDA emphasizes that pharmaceutical water must be suitable for its intended use and routinely monitored for appropriate chemical and microbiological attributes. FDA: Water for Pharmaceutical Use

What Does USP Water Testing Include?

The required testing depends on the water type, intended use and facility control strategy. A comprehensive program may include conductivity, total organic carbon, microbial enumeration, microorganism identification and bacterial endotoxin testing.

Water Conductivity: USP <645>

USP General Chapter <645> Water Conductivity provides the compendial approach for evaluating ionic impurities in pharmaceutical water. Conductivity can be affected by dissolved ions, temperature, carbon dioxide exposure, system performance and sample handling.

Conductivity is a useful chemical-quality indicator, but it does not demonstrate microbiological control. A water system may produce acceptable conductivity results while experiencing microbial proliferation or biofilm development. Chemical and microbiological results must therefore be evaluated as separate—but related—parts of the control program.

Online and offline measurements may be appropriate when the selected approach, equipment and procedures meet the applicable USP requirements. Sample exposure, temperature compensation and the time between collection and analysis should be controlled and documented.

Total Organic Carbon: USP <643>

USP General Chapter <643> Total Organic Carbon evaluates organic contamination by measuring the carbon associated with organic compounds in the sample.

Unexpected TOC changes can be associated with:

• Deterioration in purification performance
• Organic contamination in the source or feed water
• Cleaning-agent or chemical carryover
• System maintenance or component changes
• Extractables from materials in contact with the water
• Sampling-container contamination
• Improper sample handling

TOC is a nonspecific test. An elevated result indicates that additional organic carbon is present, but it does not identify the compound or its source. An investigation should consider system data, recent activities, sampling practices and related results rather than treating the TOC value as a complete explanation.

USP provides additional practical guidance on conductivity, TOC and pharmaceutical-water applications in its Water for Pharmaceutical and Analytical Purposes FAQs.

Microbiological Monitoring

Microbiological testing helps determine whether a water system remains in a controlled state. Unlike conductivity and TOC, microbiological control cannot be understood from one isolated result alone.

Recovery can be affected by:

• Sampling location and outlet design
• Whether the outlet was flushed
• Sample volume
• Collection technique
• Container suitability
• Neutralization of residual disinfectants
• Transportation and holding time
• Culture medium
• Incubation temperature and duration
• The selected enumeration method

The microbiological method should be suitable for the water system and capable of recovering the types of organisms likely to be present. Alert and action levels should reflect the water’s intended use, system performance and product risk.

Microorganism identity can be as important as the count. A low recovery of an objectionable or recurring water-associated organism may require more attention than a higher count of organisms associated with an isolated sampling event.

Bacterial Endotoxin Testing: USP <85>

Bacterial endotoxin testing is particularly important for Water for Injection and other applications in which endotoxin control is required.

Endotoxins can remain after gram-negative bacteria are no longer viable. For this reason, a low microbial count does not by itself demonstrate acceptable endotoxin control. WFI systems should be evaluated for both microbiological quality and bacterial endotoxins where required. The FDA’s high-purity-water inspection guide specifically discusses the importance of monitoring both attributes. FDA Guide to Inspections of High Purity Water Systems

Endotoxin methods must also be shown to be suitable for the sample. Interference testing helps demonstrate that the water or sample matrix does not inhibit or enhance the test response.

Qualification and Routine Monitoring Serve Different Purposes

Water-system qualification demonstrates that the installed system can consistently produce water meeting its defined requirements when operated according to approved procedures.

Qualification activities commonly evaluate:

• System installation and configuration
• Operating ranges and critical parameters
• Sanitization procedures and frequency
• Representative sampling locations
• Points of use
• Storage and distribution conditions
• Seasonal or source-water variability
• Chemical and microbiological performance
• Procedures for operation, maintenance and excursions

The sampling frequency and duration should be sufficient to understand how the system performs under expected conditions. The final approach should be scientifically justified and appropriate for the system rather than based only on a generic schedule.

Routine monitoring begins after the system has demonstrated acceptable performance. Its purpose is to confirm the continuing state of control and identify deterioration early enough to protect manufacturing operations.

Sampling Is Part of the Test Method

A laboratory result can only represent the sample received. If the sample does not represent how the water is used, even an accurate analytical result may provide misleading information.

The sampling plan should clearly define:

• The location to be sampled
• Whether the sample represents the loop, outlet or actual point of use
• Whether hoses, attachments or other use-point components are included
• Whether and how long the outlet should be flushed
• The order in which chemical and microbial samples are collected
• Required sample containers
• Any necessary neutralizers or preservatives
• Sample volume
• Storage and transportation conditions
• Maximum time before testing
• Information to document at collection

If production normally draws water through a hose, the qualification or routine sample may need to include that hose to represent actual use. Conversely, a sample collected specifically to evaluate the distribution loop may require a different procedure.

Small differences in collection practices can create large differences in recoveries. Consistent training and detailed sampling procedures are essential.

Trends Often Reveal More Than Individual Results

One acceptable result does not prove that the entire system is under control, and one unusual result does not automatically prove that the system has failed.

Water-system contamination may be intermittent. Organisms associated with biofilm can be released unevenly, creating variable counts from the same location over time. The FDA notes that contamination within a system may not be uniformly distributed and that samples can vary substantially as organisms are released from biofilm. FDA Guide to Inspections of High Purity Water Systems

Useful trending may include:

• Results by sampling location
• Alert- and action-level events
• Microorganism identities
• Repeated recovery of similar organisms
• TOC and conductivity movement
• Results before and after sanitization
• Seasonal changes
• Maintenance and system modifications
• Source-water changes
• Increasing variability at individual outlets

Microbial identification can help determine whether repeated recoveries may be connected to a water-system niche, sampling practice, maintenance activity or manufacturing environment.

Every sample tells a story, but the pattern across samples often tells the facility what is changing.

What Should Happen After an Unexpected Result?

An unexpected result should trigger a documented, scientifically sound assessment. Simply resampling until an acceptable result is obtained does not explain the original event.

An initial review should consider:

1. Sample integrity: Confirm the location, collection procedure, container, labeling, transportation and holding time.
2. Laboratory performance: Review media, reagents, instrument status, controls, incubation conditions and calculations.
3. System operation: Examine temperatures, pressures, flow, conductivity, TOC and other available process data.
4. Recent activities: Consider maintenance, sanitization, shutdowns, construction, repairs or changes in water demand.
5. Location patterns: Determine whether related or adjacent points show similar changes.
6. Microorganism identity: Evaluate whether the isolate is consistent with water-system contamination, the surrounding environment or a sampling-related event.
7. Product impact: Identify how the water was used and whether affected materials or batches require assessment.

A resample may be appropriate as part of the investigation, but it should answer a defined question. FDA enforcement communications continue to emphasize validation, routine monitoring, microbial counts and organism identity as important elements of water-system oversight. FDA warning letter example

Building a Water-Testing Program That Works in Practice

A reliable program brings together engineering, microbiology, chemistry, manufacturing and quality assurance. Before routine testing begins, manufacturers should be able to answer:

• What water quality is required for each use?
• Which USP chapters, monographs and internal specifications apply?
• Are sampling locations representative of the system and actual use?
• Are collection methods clearly defined?
• Have the analytical and microbiological methods been shown to be suitable?
• Are alert and action levels scientifically justified?
• Are organism identifications included when they can add value?
• Are results reviewed as trends rather than isolated data points?
• Is there a defined response to unexpected results?
• Can the facility connect water results with maintenance, sanitization and manufacturing activity?

These decisions should be documented before an excursion occurs. Clear expectations allow the facility and testing laboratory to respond consistently and protect data integrity.

How PlumGXP Can Support Your Water Program

PlumGXP provides flexible support for pharmaceutical water-system qualification, routine monitoring and investigations. Services can be tailored to the facility’s internal capabilities and may include:

• On-site sample collection
• Microbial enumeration and identification
• Total organic carbon testing
• Conductivity testing
• Bacterial endotoxin testing
• Sampling plans and procedure development
• Water-system qualification support
• Routine monitoring programs
• Sampling supplies and qualified containers
• Data review, trending and investigation support
• Training for facility sampling personnel

Whether a facility needs complete sampling and testing support or supplemental laboratory capacity, PlumGXP helps connect each result with the location, process and operating conditions behind it.

Know What Your Water Results Are Telling You

USP water testing should do more than demonstrate that individual samples met a limit. It should provide continuing evidence that the water system is suitable for its intended use, remains under control and can support reliable pharmaceutical manufacturing.

PlumGXP helps manufacturers develop practical water-testing programs, understand unexpected results and identify changes before they become larger compliance or production concerns.

Need help with water-system qualification, routine monitoring or an unexpected result? Contact PlumGXP to start the conversation.